Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc
(NY:
CYBN
)
0.3500
-0.0020 (-0.57%)
Official Closing Price
Updated: 8:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
36
37
Next >
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
December 11, 2022
Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From December 9, 2022
December 09, 2022
Via
Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
December 08, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 7, 2022
December 07, 2022
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Presents CYB003 Preclinical Data Amongst Leading Scientists, Academics in Neuropsychopharmacology
December 07, 2022
Via
Investor Brand Network
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
December 06, 2022
Via
Benzinga
Cybin Presents CYB003 Preclinical Data at 2022 American College of Neuropsychopharmacology Annual Meeting
December 06, 2022
From
Cybin Inc.
Via
Business Wire
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
December 05, 2022
Via
Benzinga
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD
December 03, 2022
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From December 2, 2022
December 02, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 1, 2022
December 01, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022
November 30, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
During Wednesday's session, 107 stocks hit new 52-week lows.
Via
Benzinga
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 29, 2022
Via
Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
November 28, 2022
Via
Benzinga
Cannabis Category Performances Last Week Ranged From +5.2% To -2.3%
November 27, 2022
The 5 categories in the cannabis sector perform quite differently week to week and last week was no exception. This article is a summary of how each category performed last week, in descending order...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From November 25, 2022
November 25, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
November 24, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
November 23, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
November 22, 2022
Via
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
November 21, 2022
Via
Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
November 20, 2022
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter...
Via
Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
November 18, 2022
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 17, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
November 16, 2022
Via
Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 15, 2022
Via
Benzinga
Cybin Shares Q2 Financial & Business Results, Focus On Licensing Deals For Preclinical Assets
November 15, 2022
Cybin Inc. (NYSE: CYBN) reported its unaudited financial results for its second quarter ended September 30, 2022, and provided business highlights for the period.
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Q2 Results, Recent Business Highlights, Presentation of CYB003 Preclinical Data at Neuroscience 2022
November 15, 2022
Via
Investor Brand Network
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.